Lipid metabolism reprogramming roles in mantel cell lymphoma growth and survival

نویسندگان

چکیده

Introduction: Metabolic reprogramming is a hallmark of cancer progression. However, there are few studies in mantle cell lymphoma (MCL). Protein arginine methyltransferase 5 (PRMT5), catalyzes monomethylation and symmetric demethylation residues on histone nonhistone proteins participates tumor This study aimed to investigate the mechanism PRMT5-induced lipid MCL. Method: Lymph node, bone marrow biopsy, peripheral blood specimens MCL lines were utilized as models. Liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS)-based analysis was performed measure steady-state level metabolites. GSE93291 dataset immunohistochemistry (IHC) staining determine relationship between expression levels PRMT5 patient outcome. CRISPR/Cas9 editing employed engineer loss-of-function models other key genes involved metabolism. Result: Non-targeted LC-MS/MS showed that metabolites rich (Figure 1A 1B). Through systematic metabolism-related prognosis GSE93291, PRMT5, SREBP1, SRENP2, FASN MYC found be associated with overall survival (OS) patients 1F–1J), which suggested metabolism may development IHC 105 tissues confirmed elevated significantly poor progression free (PFS) (P = 0.039) OS < 0.001) 1D 1E). Multivariate Cox regression high an independent prognostic indicator 0.003). Gene transcriptome sequencing downregulation caused reduced SREBP1/SREBP2 change metabolite 1K). depletion impaired outgrowth increased apoptosis cells. In primary samples, protein correlated 0.001). knockout blocked mRNA expression, suggesting requisite role transcription regulation. Further molecular biological methods used verify could participate through by changing 1L). Keywords: Aggressive B-cell non-Hodgkin lymphoma, Diagnostic Prognostic Biomarkers, Metabolism No conflicts interests pertinent abstract.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Key Roles of Glutamine Pathways in Reprogramming the Cancer Metabolism

Glutamine (GLN) is commonly known as an important metabolite used for the growth of cancer cells but the effects of its intake in cancer patients are still not clear. However, GLN is the main substrate for DNA and fatty acid synthesis. On the other hand, it reduces the oxidative stress by glutathione synthesis stimulation, stops the process of cancer cachexia, and nourishes the immunological sy...

متن کامل

Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics

Prostate cancer (PCa) metastasizes to bone and soft tissues, greatly decreasing quality of life, causing bone pain, skeletal complications, and mortality in PCa patients. While new treatment strategies are being developed, the molecular and cellular basis of PCa metastasis and the "cross-talk" between cancer cells and their microenvironment and crucial cell signaling pathways need to be success...

متن کامل

Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death

Little is known about the regulation of nonapoptotic cell death. Using massive insertional mutagenesis of haploid KBM7 cells we identified nine genes involved in small-molecule-induced nonapoptotic cell death, including mediators of fatty acid metabolism (ACSL4) and lipid remodeling (LPCAT3) in ferroptosis. One novel compound, CIL56, triggered cell death dependent upon the rate-limiting de novo...

متن کامل

Opposing Roles of NO and Rho-Kinase in Lipid Metabolism

171 Received December 26, 2014; revised and accepted February 9, 2015. Published online March 3, 2015; doi: 10.1620/tjem.235.171. Correspondence: Hiroaki Shimokawa, M.D., Ph.D., Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. e-mail: [email protected] Opposing Roles of Nitric Oxide and R...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Hematological Oncology

سال: 2023

ISSN: ['1099-1069', '0278-0232']

DOI: https://doi.org/10.1002/hon.3164_167